148 related articles for article (PubMed ID: 27711011)
1. The role of antibody induction in liver transplantation.
Eason JD
Curr Opin Organ Transplant; 2007 Jun; 12(3):242-244. PubMed ID: 27711011
[TBL] [Abstract][Full Text] [Related]
2. Induction immunosuppression in liver transplantation: a review.
Turner AP; Knechtle SJ
Transpl Int; 2013 Jul; 26(7):673-83. PubMed ID: 23651083
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
[TBL] [Abstract][Full Text] [Related]
5. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression in Liver Transplantation: State of the Art and Future Perspectives.
Nedredal GI; Picon RV; Chedid MF; Foss A
Curr Pharm Des; 2020; 26(28):3389-3401. PubMed ID: 32520679
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal versus monoclonal induction therapy in a calcineurin inhibitor-free immunosuppressive therapy in renal transplantation: a comparison of efficacy and costs.
Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofan F; Fernandez E; Campistol JM; Oppenheimer F
Transplant Proc; 2015; 47(1):45-9. PubMed ID: 25645767
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in liver transplantation: beyond calcineurin inhibitors.
Fung J; Kelly D; Kadry Z; Patel-Tom K; Eghtesad B
Liver Transpl; 2005 Mar; 11(3):267-80. PubMed ID: 15719409
[TBL] [Abstract][Full Text] [Related]
10. Use of antibody induction in pediatric renal transplantation.
Pescovitz MD
Curr Opin Organ Transplant; 2008 Oct; 13(5):495-9. PubMed ID: 19060532
[TBL] [Abstract][Full Text] [Related]
11. Current status of liver transplantation in children.
McDiarmid SV
Pediatr Clin North Am; 2003 Dec; 50(6):1335-74. PubMed ID: 14710783
[TBL] [Abstract][Full Text] [Related]
12. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
Hardinger KL
Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
[TBL] [Abstract][Full Text] [Related]
13. Current concepts and perspectives of immunosuppression in organ transplantation.
Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ
Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373
[TBL] [Abstract][Full Text] [Related]
14. Use of antilymphocyte induction therapy in liver transplantation.
Wall WJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
[TBL] [Abstract][Full Text] [Related]
15. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE
PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152
[TBL] [Abstract][Full Text] [Related]
16. Anti-IL-2 receptor antibody vs. polyclonal anti-lymphocyte antibody as induction therapy in pediatric transplantation.
Di Filippo S
Pediatr Transplant; 2005 Jun; 9(3):373-80. PubMed ID: 15910396
[TBL] [Abstract][Full Text] [Related]
17. Options for induction immunosuppression in liver transplant recipients.
Moser MA
Drugs; 2002; 62(7):995-1011. PubMed ID: 11985487
[TBL] [Abstract][Full Text] [Related]
18. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
Nashan B
BioDrugs; 2005; 19(1):39-46. PubMed ID: 15691216
[TBL] [Abstract][Full Text] [Related]
19. Daclizumab: a review of its use in the management of organ transplantation.
Carswell CI; Plosker GL; Wagstaff AJ
BioDrugs; 2001; 15(11):745-73. PubMed ID: 11707149
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in liver transplantation.
Mukherjee S; Botha JF; Mukherjee U
Curr Drug Targets; 2009 Jun; 10(6):557-74. PubMed ID: 19519358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]